Pharmaceutical / Drug Definition :
Inhibits protein translation in bacteria by binding to 30S ribosomal subunit and blocking entry of amino-acyl tRNA molecules into ribosomal A site, which in turn prevents incorporation of amino acid residues into elongating peptide chains
FDA Detentions
Tigecycline (Tigecycline Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Tigecycline (Tigecycline Suppliers)
- Processors Tigecycline
- Repackers Tigecycline
- Relabelers Tigecycline
- Exporters Tigecycline
- Importers Tigecycline
For more information about Tigecycline, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
